Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thrombocythaemia and pregnancy.

Michelle A Elliott1, Ayalew Tefferi

  • 1Department of Hematology and Internal Medicine, Section of Scientific Publications, Mayo Clinic and Mayo Foundation, Mayo Medical School, 200 First Street SW, Rochester, MN 55905, USA.

Best Practice & Research. Clinical Haematology
|May 24, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Monocytosis in polycythemia vera: Clinical and molecular correlates.

American journal of hematology·2017
Same author

Socioeconomic burden of participation in clinical trials in patients with myeloproliferative neoplasms.

European journal of haematology·2017
Same author

Targeted next generation sequencing and identification of risk factors in World Health Organization defined atypical chronic myeloid leukemia.

American journal of hematology·2017
Same author

Downregulation of GATA1 drives impaired hematopoiesis in primary myelofibrosis.

The Journal of clinical investigation·2017
Same author

The prognostic relevance of serum lactate dehydrogenase and mild bone marrow reticulin fibrosis in essential thrombocythemia.

American journal of hematology·2017
Same author

Diagnostic impact of the 2016 revised who criteria for polycythemia vera.

American journal of hematology·2017
Same journal

CAR-T cell therapy for multiple myeloma: An update on the current state and future potential.

Best practice & research. Clinical haematology·2025
Same journal

Cancer vaccines in hematologic malignancy: A systematic review of the rational and evidence for clinical use.

Best practice & research. Clinical haematology·2025
Same journal

Immune therapy of haematological cancers.

Best practice & research. Clinical haematology·2025
Same journal

Advances in NK cell therapy for multiple myeloma.

Best practice & research. Clinical haematology·2025
Same journal

Adoptive cellular therapies in multiple myeloma.

Best practice & research. Clinical haematology·2025
Same journal

Bispecific T-cell engager therapy for multiple myeloma.

Best practice & research. Clinical haematology·2025
See all related articles

Essential thrombocythaemia (ET) management during pregnancy requires careful consideration due to increased risks. This review provides guidelines based on current evidence for optimal outcomes in patients with ET.

Area of Science:

  • Hematology
  • Obstetrics
  • Reproductive Medicine

Background:

  • Essential thrombocythaemia (ET) is a chronic myeloproliferative disorder with a notable proportion of young and female patients.
  • ET diagnosis requires excluding secondary causes of thrombocytosis.
  • Pregnancy in women with ET presents unique challenges and risks.

Purpose of the Study:

  • To review the association between essential thrombocythaemia and pregnancy.
  • To provide evidence-based management guidelines for ET during pregnancy.
  • To counsel prospective parents on risks and optimal care.

Main Methods:

  • Review of existing literature and investigator experiences.
  • Analysis of obstetric and maternal complications in ET pregnancies.

Related Experiment Videos

  • Development of management recommendations based on available data.

    • Main Results:

    • ET is not a contraindication to childbearing but increases maternal and fetal risks.
    • Increased rates of first-trimester spontaneous abortion are observed.
    • Hemorrhagic and thrombotic maternal complications are infrequent but possible.

    Conclusions:

    • Optimal management of ET during pregnancy is crucial due to potential complications.
    • Limited data from controlled trials necessitate guidelines based on collective experience.
    • Counseling regarding risks is essential for prospective parents with ET.